Significance of Irisin (FNDC5) Expression in Colorectal Cancer

被引:8
|
作者
Wozniak, Slawomir [1 ]
Nowinska, Katarzyna [2 ]
Chabowski, Mariusz [3 ,4 ]
Dziegiel, Piotr [2 ]
机构
[1] Wroclaw Med Univ, Dept Human Morphol & Embryol, Div Anat, Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Human Morphol & Embryol, Div Histol & Embryol, Chalubinskiego St 6a, PL-50368 Wroclaw, Poland
[3] 4th Mil Surg Clin Wroclaw, Wroclaw, Poland
[4] Wroclaw Med Univ, Fac Hlth Sci, Dept Nursing & Obstet, Div Anesthesiol & Surg Nursing, Wroclaw, Poland
来源
IN VIVO | 2022年 / 36卷 / 01期
关键词
FNDC5; irisin; colorectal cancer; Ki-67; CELL-PROLIFERATION; FAT;
D O I
10.21873/invivo.12689
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: The role of irisin, the extracellular part of fibronectin type III domain containing 5 (FNDC5), in colorectal cancer (CRC) is unclear. The aim of this study was to investigate immunohistochemical (IHC) expression level of irisin and correlations with clinicopathological factors in patients with CRC. Materials and Methods: We collected 222 archived CRC samples and 26 control samples from autopsies conducted at the Department of Forensic Medicine. They were used to perform IHC reactions detecting irisin, Ki-67, minichromosome maintenance protein complex component 3 (MCM3), and urine diphosphate-galactose ceramide galactosyltransferase (UGT3) expression. The correlations with Ki-67, MCM3, and UGT3 were analyzed. Irisin expression was also evaluated in cancer cell lines by immunofluorescence reaction and western blot. Results: Irisin expression was higher in cancer cells compared to the control tissues (p<0.0001). Irisin expression was significantly higher in stage I than in stage III (p=0.013) and IV CRC (p=0.05). Conclusion: The correlation between higher expression of irisin and cancer stages indicates its potential usefulness as a marker in CRC.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 50 条
  • [1] Expression of Irisin/FNDC5 in Breast Cancer
    Cebulski, Kamil
    Nowinska, Katarzyna
    Jablonska, Karolina
    Romanowicz, Hanna
    Smolarz, Beata
    Dziegiel, Piotr
    Podhorska-Okolow, Marzenna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [2] Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer
    Xu, Luyun
    Ye, Yan
    Sun, Yuqin
    Zhong, Wenting
    Chi, Liangjie
    Lin, Youyu
    Liu, Hongxia
    Li, ShengZhao
    Chen, Hui
    Li, Chengcheng
    Lin, Yuxuan
    Wang, Qingshui
    Xue, Fangqin
    Lin, Yao
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer
    Cebulski, Kamil
    Piotrowska, Aleksandra
    Kmiecik, Alicja
    Haczkiewicz-Lesniak, Katarzyna
    Ciesielska, Urszula
    Grzegrzolka, Jedrzej
    Jablonska, Karolina
    Romanowicz, Hanna
    Smolarz, Beata
    Dziegiel, Piotr
    Podhorska-Okolow, Marzenna
    Nowinska, Katarzyna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [4] FNDC5/Irisin: Physiology and Pathophysiology
    Waseem, Rashid
    Shamsi, Anas
    Mohammad, Taj
    Hassan, Md. Imtaiyaz
    Kazim, Syed Naqui
    Chaudhary, Anis Ahmad
    Rudayni, Hassan Ahmed
    Al-Zharani, Mohammed
    Ahmad, Faizan
    Islam, Asimul
    [J]. MOLECULES, 2022, 27 (03):
  • [5] Increased FNDC5/Irisin expression in human hepatocellular carcinoma
    Gaggini, Melania
    Cabiati, Manuela
    Del Turco, Serena
    Navarra, Teresa
    De Simone, Paolo
    Filipponi, Franco
    Del Ry, Silvia
    Gastaldelli, Amalia
    Basta, Giuseppina
    [J]. PEPTIDES, 2017, 88 : 62 - 66
  • [6] The diagnostic value of FNDC5/Irisin in Renal Cell Cancer
    Altay, Diler Us
    Keha, Esref Edip
    Karaguzel, Ersagun
    Mentese, Ahmet
    Yaman, Serap Ozer
    Alver, Ahmet
    [J]. INTERNATIONAL BRAZ J UROL, 2018, 44 (04): : 734 - 739
  • [7] Irisin/FNDC5: A participant in camel metabolism
    Kirat, Doaa
    Hamada, Mohamed
    Moustafa, Amira
    Miyasho, Taku
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (01) : 693 - 706
  • [8] The cerebroprotection and prospects of FNDC5/irisin in stroke
    Liu, Yuanyuan
    Liu, Yang
    Zhang, Xiangyu
    Yan, Gaili
    Qi, Lingxiao
    Yong, V. Wee
    Xue, Mengzhou
    [J]. NEUROPHARMACOLOGY, 2024, 253
  • [9] Progress and Challenges in the Biology of FNDC5 and Irisin
    Maak, Steffen
    Norheim, Frode
    Drevon, Christian A.
    Erickson, Harold P.
    [J]. ENDOCRINE REVIEWS, 2021, 42 (04) : 436 - 456
  • [10] The Role of FNDC5/Irisin in Cardiovascular Disease
    Grzeszczuk, Maciej
    Dziegiel, Piotr
    Nowinska, Katarzyna
    [J]. CELLS, 2024, 13 (03)